Symeres
Rory Curtis has a vast experience in the biotechnology and pharmaceutical industry, holding various leadership positions such as Vice President of Business Development at Symeres, Vice President of Drug Discovery at AMRI, and Strategic Advisor at Constellation Pharmaceuticals. With a background in Biochemistry and Neurobiology, Rory has provided consulting services to a range of companies and established their own biotech consulting firm. Rory's expertise lies in developing drugs for age-related diseases and histone-modifying enzymes, contributing significantly to the industry.
This person is not in any offices
Symeres
1 followers
Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug-discovery and development challenges. With around 700 highly educated scientists in six locations in Europe and two the USA, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care. Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. We blend vast scientific knowledge with inventiveness to make great leaps on your behalf. Making Molecules Matter. Together.